BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $628,984 | -38.2% | 16,666 | -25.4% | 0.01% | -38.1% |
Q2 2023 | $1,018,412 | +39.7% | 22,353 | +24.3% | 0.02% | +23.5% |
Q1 2023 | $729,088 | +104.8% | 17,976 | +171.7% | 0.02% | +70.0% |
Q3 2022 | $356,000 | +76.2% | 6,616 | +110.0% | 0.01% | +66.7% |
Q2 2022 | $202,000 | -52.2% | 3,150 | -42.3% | 0.01% | -40.0% |
Q1 2022 | $423,000 | -5.4% | 5,456 | +4.7% | 0.01% | 0.0% |
Q4 2021 | $447,000 | +4.9% | 5,210 | -1.5% | 0.01% | -9.1% |
Q3 2021 | $426,000 | +34.8% | 5,289 | +34.6% | 0.01% | +22.2% |
Q2 2021 | $316,000 | +14.1% | 3,930 | +19.7% | 0.01% | -18.2% |
Q1 2021 | $277,000 | -15.3% | 3,282 | -18.5% | 0.01% | -57.7% |
Q1 2020 | $327,000 | +23.4% | 4,028 | +26.8% | 0.03% | +13.0% |
Q4 2019 | $265,000 | – | 3,176 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tavio Capital LLC | 68,405 | $5,890,000 | 7.81% |
Iron Triangle Partners LP | 330,000 | $28,413,000 | 7.16% |
Veritas Asset Management LLP | 8,942,428 | $769,943,000 | 5.64% |
TSFG, LLC | 93,405 | $8,042,000 | 5.31% |
GENERATION INVESTMENT MANAGEMENT LLP | 10,606,094 | $913,185,000 | 5.27% |
Third Point | 4,000,000 | $344,400,000 | 4.72% |
Avidity Partners Management LP | 800,900 | $68,957,000 | 4.42% |
Palmer Knight Co | 62,275 | $5,362,000 | 4.17% |
Eos Focused Equity Management, L.P. | 36,786 | $3,167,000 | 3.70% |
Dundas Partners LLP | 196,133 | $16,887,000 | 3.69% |